AI-Assisted Camera-Based Progressive Muscle Relaxation for Office Workers (AI-PMR)
17 de maio de 2026 atualizado por: dogukan kurc, Istanbul Medipol University Hospital
Effectiveness of an AI-Assisted Camera-Based Progressive Muscle Relaxation Application in Office Workers: A Randomized Controlled Trial
This randomized controlled trial evaluates the effectiveness of an AI-assisted, camera-based progressive muscle relaxation application in office workers aged 20 to 40 years.
Participants are randomly allocated to an intervention group or a control group.
The intervention group completes a 4-week progressive muscle relaxation program using the PhysioTR Academic application, which provides camera-based real-time movement analysis and exercise guidance.
The control group continues their usual daily routine and completes baseline and post-intervention assessments only.
Outcomes include pain/tension intensity, musculoskeletal symptoms, perceived stress, neck disability, work productivity, functionality, and AI-based adherence metrics.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
This study is a single-center, randomized, controlled, open-label trial conducted in office workers aged 20 to 40 years. Participants are automatically randomized into either an intervention group or a control group.
The intervention group uses the PhysioTR Academic application for a 4-week progressive muscle relaxation program. The program includes 3 sessions per week, 12 sessions in total. Each session includes four exercise components: face and jaw, neck and shoulders, hands and arms, and back and chest. Each exercise includes a contraction and relaxation phase. The application uses the participant's device camera for real-time movement analysis and provides written and/or audio guidance.
The control group continues their usual daily routine and does not receive an exercise intervention during the study period. The control group completes only baseline and post-intervention assessments.
Assessments are performed at baseline and Week 4. Outcome measures include the Visual Analog Scale, Nordic Musculoskeletal Questionnaire, Perceived Stress Scale, Neck Disability Index, Work Productivity Scale, numeric functionality score, and AI-based adherence and landmark coverage metrics in the intervention group.
Tipo de estudo
Intervencional
Inscrição (Real)
60
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Beykoz
-
Istanbul, Beykoz, Turquia (Türkiye), 34810
- Istanbul Medipol University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Aged between 20 and 40 years
- Actively working in a desk-based or office-based job
- Having access to a camera-enabled device such as a smartphone or computer
- Voluntary participation with informed consent
- Able to read and write Turkish
- Having a valid e-mail address
Exclusion Criteria:
- Previous surgery involving the neck or spine
- Cervical vertebral fracture or instability
- History of neurological disease such as multiple sclerosis or Parkinson's disease
- Vestibular system disorder
- Systemic inflammatory disease such as rheumatoid arthritis or ankylosing spondylitis
- History of malignancy
- Pregnancy
- Having received physiotherapy for the neck or back region within the last 6 months
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: AI-Assisted Camera-Based Progressive Muscle Relaxation Group
Participants in this group complete a 4-week progressive muscle relaxation program using the PhysioTR Academic application.
The program includes 3 sessions per week, 12 sessions in total.
Each session includes four components: face and jaw, neck and shoulders, hands and arms, and back and chest.
The application uses the participant's device camera for real-time movement analysis and records session-level Visual Analog Scale scores and AI-based adherence metrics.
|
A camera-based progressive muscle relaxation program delivered through the PhysioTR Academic web application.
The intervention includes 4 weeks of training, 3 sessions per week, for a total of 12 sessions.
The application provides written and/or audio instructions and uses camera-based real-time movement analysis to support exercise performance and adherence monitoring.
|
|
Sem intervenção: Control Group
Participants in the control group continue their usual daily routine and do not receive an exercise intervention during the study period.
They complete baseline and Week 4 assessments only.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Pain/Tension Intensity Assessed by Visual Analog Scale
Prazo: Baseline and Week 4
|
Pain/tension intensity is assessed using a 0-10 Visual Analog Scale.
Higher scores indicate greater pain/tension intensity.
Change is calculated from baseline to Week 4.
|
Baseline and Week 4
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Musculoskeletal Symptoms Assessed by the Nordic Musculoskeletal Questionnaire
Prazo: Baseline and Week 4
|
Musculoskeletal symptoms are assessed using the Nordic Musculoskeletal Questionnaire across body regions.
The outcome is summarized as the presence of symptoms by region and/or the number of symptomatic body regions.
Higher values indicate more widespread musculoskeletal symptoms.
|
Baseline and Week 4
|
|
Change in Perceived Stress Scale Score
Prazo: Baseline and Week 4
|
Perceived stress is assessed using the Turkish version of the Perceived Stress Scale.
Higher scores indicate greater perceived stress.
|
Baseline and Week 4
|
|
Change in Neck Disability Index Score
Prazo: Baseline and Week 4
|
Neck-related disability is assessed using the Neck Disability Index.
Higher scores indicate greater neck-related disability.
|
Baseline and Week 4
|
|
Change in Work Productivity Scale Score
Prazo: Baseline and Week 4
|
Work productivity is assessed using a 5-item Likert-type Work Productivity Scale.
Total scores range from 5 to 25, with higher scores indicating higher work productivity.
|
Baseline and Week 4
|
|
Change in Numeric Functionality Score
Prazo: Baseline and Week 4
|
General functionality is assessed using a numeric rating scale from 0 to 10, where 0 indicates very poor functionality and 10 indicates excellent functionality.
Higher scores indicate better functionality.
|
Baseline and Week 4
|
|
AI-Based Exercise Adherence Score
Prazo: During each of the 12 sessions over the 4-week intervention period
|
In the intervention group, the application automatically calculates an AI-based adherence score as the percentage of predefined exercise criteria met during each session.
Scores range from 0 to 100%, with higher scores indicating better adherence to the required exercise form.
|
During each of the 12 sessions over the 4-week intervention period
|
|
AI-Based Landmark Coverage Ratio
Prazo: During each of the 12 sessions over the 4-week intervention period
|
In the intervention group, the application calculates a landmark coverage ratio as the percentage of required body landmarks detected by the camera during each exercise.
Scores range from 0 to 100%, with higher scores indicating better camera-based landmark detection.
|
During each of the 12 sessions over the 4-week intervention period
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Immediate Change in Session-Level Pain/Tension Intensity
Prazo: Immediately before and after each session during the 4-week intervention period
|
In the intervention group, pain/tension intensity is recorded immediately before and after each progressive muscle relaxation session using a 0-10 Visual Analog Scale.
The immediate session-level change is calculated as post-session score minus pre-session score.
|
Immediately before and after each session during the 4-week intervention period
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
8 de abril de 2026
Conclusão Primária (Real)
13 de maio de 2026
Conclusão do estudo (Real)
13 de maio de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
30 de abril de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
30 de abril de 2026
Primeira postagem (Real)
7 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
20 de maio de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
17 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- PHYSIOTR-PMR-2026-001
- Ethics Approval No. 515 (Outro identificador: Istanbul Medipol University)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Individual participant data will not be publicly shared due to ethical approval conditions and personal data protection requirements.
De-identified aggregate data may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethics approval.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .